Jane Street

Jane Street Portfolio holdings

AUM $62B
1-Year Return 4.11%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Quarter Return
+0.62%
1 Year Return
+4.11%
3 Year Return
+15.25%
5 Year Return
+21.47%
10 Year Return
+49.61%
AUM
$13.7B
AUM Growth
+$883M
Cap. Flow
+$703M
Cap. Flow %
5.12%
Top 10 Hldgs %
20.42%
Holding
4,178
New
1,007
Increased
1,147
Reduced
1,028
Closed
842

Sector Composition

1 Consumer Discretionary 10.13%
2 Technology 8.58%
3 Financials 5.77%
4 Healthcare 5.02%
5 Communication Services 4.94%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GST
2926
DELISTED
Gastar Exploration Inc.
GST
$94K ﹤0.01%
+168,451
New +$94K
APVO icon
2927
Aptevo Therapeutics
APVO
$4.83M
0
EYPT icon
2928
EyePoint Pharmaceuticals
EYPT
$920M
$92K ﹤0.01%
+4,434
New +$92K
NEPT
2929
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$92K ﹤0.01%
+21
New +$92K
GNCA
2930
DELISTED
Genocea Biosciences, Inc.
GNCA
$92K ﹤0.01%
+13,388
New +$92K
GALT icon
2931
Galectin Therapeutics
GALT
$344M
$91K ﹤0.01%
+14,369
New +$91K
OCUL icon
2932
Ocular Therapeutix
OCUL
$2.23B
$91K ﹤0.01%
+13,489
New +$91K
AFH
2933
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$91K ﹤0.01%
+10,413
New +$91K
CLDX icon
2934
Celldex Therapeutics
CLDX
$1.62B
$89K ﹤0.01%
+11,808
New +$89K
SNES icon
2935
SenesTech
SNES
$26.9M
$88K ﹤0.01%
+1
New +$88K
ADXS
2936
DELISTED
Advaxis, Inc.
ADXS
$88K ﹤0.01%
+4,069
New +$88K
FG
2937
DELISTED
FGL Holdings Ordinary Shares
FG
$88K ﹤0.01%
10,497
-44,442
-81% -$373K
DEST
2938
DELISTED
Destination Maternity Corporation
DEST
$88K ﹤0.01%
+15,161
New +$88K
IVTY
2939
DELISTED
Invuity, Inc
IVTY
$88K ﹤0.01%
+22,637
New +$88K
PTGX icon
2940
Protagonist Therapeutics
PTGX
$3.66B
$87K ﹤0.01%
+12,945
New +$87K
BLDP
2941
Ballard Power Systems
BLDP
$622M
$86K ﹤0.01%
30,189
-3,952
-12% -$11.3K
BKCC
2942
DELISTED
BlackRock Capital Investment Corporation
BKCC
$84K ﹤0.01%
14,343
-9,615
-40% -$56.3K
UAVS icon
2943
AgEagle Aerial Systems
UAVS
$61.3M
$83K ﹤0.01%
+45
New +$83K
GSS
2944
DELISTED
Golden Star Resources Ltd.
GSS
$81K ﹤0.01%
24,136
+15,947
+195% +$53.5K
TEN
2945
Tsakos Energy Navigation Ltd.
TEN
$672M
$80K ﹤0.01%
+4,281
New +$80K
PIR
2946
DELISTED
Pier 1 Imports, Inc.
PIR
$80K ﹤0.01%
+1,680
New +$80K
OCSL icon
2947
Oaktree Specialty Lending
OCSL
$1.21B
$80K ﹤0.01%
5,579
-2,854
-34% -$40.9K
TIS
2948
DELISTED
Orchids Paper Products, Inc.
TIS
$79K ﹤0.01%
+19,807
New +$79K
COCP icon
2949
Cocrystal Pharma
COCP
$16.2M
$78K ﹤0.01%
+1,787
New +$78K
FRAN
2950
DELISTED
Francesca's Holdings Corporation
FRAN
$78K ﹤0.01%
+856
New +$78K